Page 3 - Bttx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bttx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bttx Today - Breaking & Trending Today

NetEase, Inc. (NASDAQ:NTES) Short Interest Down 18.9% in April

Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) was the recipient of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 129,800 shares, a decrease of 30.3% from the April 15th total of 186,200 shares. Currently, 6.7% of the company’s shares are short sold. Based […] ....

Frank Karbe , Geoffreym Parker , Better Therapeutics Inc , Exchange Commission , Securities Exchange Commission , Better Therapeutics , Get Rating , Street Capital , Lifesci Capital , Director Geoffrey , Street Corp , Better Therapeutics Daily , Nasdaq Bttx ,

Better Therapeutics, Inc. (NASDAQ:BTTX) Short Interest Update

Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 186,200 shares, a growth of 51.4% from the March 31st total of 123,000 shares. Approximately 8.1% of the shares of the company are sold short. Based on […] ....

Geoffreym Parker , Frank Karbe , Vanguard Group Inc , Better Therapeutics Company Profile , Better Therapeutics Inc , Better Therapeutics , Get Rating , Lake Street Capital , Therapeutics Stock Down , Director Geoffrey , Better Therapeutics Daily , Nasdaq Bttx ,

Metaverse Dualchain Network Architecture (DNA) Price Up 0% This Week

Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 186,200 shares, a growth of 51.4% from the March 31st total of 123,000 shares. Based on an average daily trading volume, of 78,500 shares, the days-to-cover ratio […] ....

Frank Karbe , Geoffreym Parker , Exchange Commission , Securities Exchange Commission , Better Therapeutics Inc , Better Therapeutics , Get Rating , Street Capital , Lifesci Capital , Director Geoffrey , Street Corp , Better Therapeutics Daily , Nasdaq Bttx ,

Short Interest in Better Therapeutics, Inc. (NASDAQ:BTTX) Increases By 51.4%

Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 186,200 shares, a growth of 51.4% from the March 31st total of 123,000 shares. Approximately 8.1% of the company’s stock are sold short. Based on an average […] ....

Frank Karbe , Geoffreym Parker , Vanguard Group Inc , Better Therapeutics Inc , Securities Exchange Commission , Better Therapeutics , Get Rating , Director Geoffrey , Exchange Commission , Street Capital , Lifesci Capital , Better Therapeutics Daily , Nasdaq Bttx ,

Lake Street Capital Cuts Better Therapeutics (NASDAQ:BTTX) Price Target to $5.00

Better Therapeutics (NASDAQ:BTTX – Get Rating) had its price objective trimmed by Lake Street Capital from $6.00 to $5.00 in a report published on Friday morning, The Fly reports. A number of other brokerages have also issued reports on BTTX. Lifesci Capital lowered shares of Better Therapeutics from an outperform rating to a market perform […] ....

Geoffreym Parker , Frank Karbe , Vanguard Group Inc , Securities Exchange Commission , Better Therapeutics Company Profile , Better Therapeutics Inc , Exchange Commission , Better Therapeutics , Get Rating , Lake Street Capital , Director Geoffrey , Better Therapeutics Daily , Nasdaq Bttx , Lower Price Target ,